LAPACT: An open-label, multicenter phase II trial of <i>nab</i>-paclitaxel (<i>nab</i>-P) plus gemcitabine (Gem) in patients (pts) with locally advanced pancreatic cancer (LAPC).Philip Agop Philip, Pascal Hammel, Jill Lacy et al.|Journal of Clinical Oncology|2016Cited by 3
Effect of statins on risk of pancreatic cancer: A meta-analysis of randomized controlled trials (RCTs) and observational studies (OS).Ahmad Cheema, Wasif M. Saif, Hafeez Hassan et al.|Journal of Clinical Oncology|2016Cited by 1